Ventilator-dependent pneumonia due to resistant Acinetobacter.
Conditions
Interventions
Intervention 1: Intervention group 1: The patients of this group receive intravenous ampicillin sulbactam at a dose of 9 grams every 8 hours for 10-14 days, each dose is infused over 4 hours along wit
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients over 18 years old with ventilator-dependent pneumonia due to resistant Acinetobacter
Exclusion criteria
Exclusion criteria: Immunocompromised patients and extubated patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determining the effectiveness of treatment in improving the clinical condition. Timepoint: 3, 5, and 7 days after starting the treatment. Method of measurement: Improving respiratory condition and reducing lung secretions and extubation and stopping fever.;Determining the effectiveness of treatment in improving laboratory conditions. Timepoint: 3, 5 and 7 days after the start of treatment. Method of measurement: Check complete blood tests and inflammatory factors. | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of hospitalization in the intensive care unit and hospital. Timepoint: Length of hospitalization. Method of measurement: Check list.;Mortality rate. Timepoint: End of study. Method of measurement: Check list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Honarjou
Mashhad University of Medical Sciences
Outcome results
None listed